Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such
08 Dec 2022
VaccineDrug Approval
Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such
COPENHAGEN, Denmark, December 8, 2022 – Bavarian Nordic A/S (OMX: BAVA) has today received information about the following transactions of the company’s shares/related securities by persons holding managerial responsibilities and/or persons/companies closely associated with such.
1.Details of the person discharging managerial responsibilities/person closely associated a)NamePaul Chaplin2.Reason for the notificationa)Position/status
President and Chief Executive Officer of Bavarian Nordic A/S b)Initial notification/AmendmentInitial notification3.Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitora)NameBavarian Nordic A/Sb)LEI2138006JCDVYIN6INP514.Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducteda)Description of the financial instrument, type of instrument
Identification codeWarrants
DK0015998017b)Nature of the transactionGrantc)Price(s) and volume(s)Price(s)Volume(s) DKK 0.0088,325d)Aggregated information
Aggregated volume
Price
88,325
DKK 0.00e)Date of the transaction2022-12-08f)Place of the transactionOutside a trading venue
1.Details of the person discharging managerial responsibilities/person closely associated a)NameHenrik Juuel2.Reason for the notificationa)Position/status
Executive Vice President and Chief Financial Officer of Bavarian Nordic A/Sb)Initial notification/AmendmentInitial notification3.Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitora)NameBavarian Nordic A/Sb)LEI2138006JCDVYIN6INP514.Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducteda)Description of the financial instrument, type of instrument
Identification codeWarrants
DK0015998017b)Nature of the transactionGrantc)Price(s) and volume(s)Price(s)Volume(s) DKK 0.0038,162d)Aggregated information
Aggregated volume
Price
38,162
DKK 0.00e)Date of the transaction2022-12-08f)Place of the transactionOutside a trading venue
1.Details of the person discharging managerial responsibilities/person closely associated a)NameJean-Christophe May2.Reason for the notificationa)Position/status
Executive Vice President and Chief Commercial Officer of Bavarian Nordic A/Sb)Initial notification/AmendmentInitial notification3.Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitora)NameBavarian Nordic A/Sb)LEI2138006JCDVYIN6INP514.Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducteda)Description of the financial instrument, type of instrument
Identification codeWarrants
DK0015998017b)Nature of the transactionGrantc)Price(s) and volume(s)Price(s)Volume(s) DKK 0.0034,263d)Aggregated information
Aggregated volume
Price
34,263
DKK 0.00e)Date of the transaction2022-12-08f)Place of the transactionOutside a trading venue
1.Details of the person discharging managerial responsibilities/person closely associated a)NameLaurence De Moerlooze2.Reason for the notificationa)Position/status
Executive Vice President and Chief Medical Officer of Bavarian Nordic A/Sb)Initial notification/AmendmentInitial notification3.Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitora)NameBavarian Nordic A/Sb)LEI2138006JCDVYIN6INP514.Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducteda)Description of the financial instrument, type of instrument
Identification codeWarrants
DK0015998017b)Nature of the transactionGrantc)Price(s) and volume(s)Price(s)Volume(s) DKK 0.0032,934d)Aggregated information
Aggregated volume
Price
32,934
DKK 0.00e)Date of the transaction2022-12-08f)Place of the transactionOutside a trading venue
1.Details of the person discharging managerial responsibilities/person closely associated a)NameAnu Helena Kerns2.Reason for the notificationa)Position/status
Executive Vice President People & Organization of Bavarian Nordic A/Sb)Initial notification/AmendmentInitial notification3.Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitora)NameBavarian Nordic A/Sb)LEI2138006JCDVYIN6INP514.Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducteda)Description of the financial instrument, type of instrument
Identification codeWarrants
DK0015998017b)Nature of the transactionGrantc)Price(s) and volume(s)Price(s)Volume(s) DKK 0.0022,902d)Aggregated information
Aggregated volume
Price
22,902
DKK 0.00e)Date of the transaction2022-12-08f)Place of the transactionOutside a trading venue
1.Details of the person discharging managerial responsibilities/person closely associated a)NameRussell Thirsk2.Reason for the notificationa)Position/status
Executive Vice President and Chief Operating Officer of Bavarian Nordic A/Sb)Initial notification/AmendmentInitial notification3.Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitora)NameBavarian Nordic A/Sb)LEI2138006JCDVYIN6INP514.Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducteda)Description of the financial instrument, type of instrument
Identification codeWarrants
DK0015998017b)Nature of the transactionGrantc)Price(s) and volume(s)Price(s)Volume(s) DKK 0.0032,201d)Aggregated information
Aggregated volume
Price
32,201
DKK 0.00e)Date of the transaction2022-12-08f)Place of the transactionOutside a trading venue About Bavarian Nordic
Bavarian Nordic is a fully integrated vaccines company focused on the development, manufacturing and commercialization of life-saving vaccines. We are a global leader in smallpox vaccines and have been a long-term supplier to the U.S. Government of a non-replicating smallpox vaccine, which has been approved by the FDA, also for the protection against mpox (monkeypox). The vaccine is also approved in Canada and Europe. Our commercial product portfolio furthermore contains market-leading vaccines against rabies and tick-borne encephalitis. Using our live virus vaccine platform technology, MVA-BN®, we have created a diverse portfolio of proprietary and partnered product candidates designed to save and improve lives by unlocking the power of the immune system, including an Ebola vaccine, which is licensed to the Janssen Pharmaceutical Companies of Johnson & Johnson. We are also committed to the development of a next generation COVID-19 vaccineCOVID-19 vaccine. For more information visit www.bavarian-nordic.com.
Contacts
Europe: Rolf Sass Sørensen, Vice President Investor Relations, Tel: +45 61 77 47 43
US: Graham Morrell, Paddock Circle Advisors, graham@paddockcircle.com, Tel: +1 781 686 9600
Company Announcement no. 44 / 2022
2022-44-en
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
Targets
-Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.